RGLS
Regulus Therapeutics Inc.
Director Stelios Papadopoulos bought $55K of Regulus Therapeutics Inc.
Bought$54,570
$1.09Price
50,000Shares
+6%Stake
What RGLS did for a copier
Prices for RGLS after this filing aren't in yet.
Stelios Papadopoulos's record
5 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Dec 28. Filed Wed, Jan 2, 4:12 PM ET, after the close. Not investment advice.